reSee.it - Related Video Feed

They have discovered a potential breakthrough in cancer treatment using mRNA technology similar to COVID vaccines. By biopsying a patient's cancer, extracting its protein, and reintroducing it into the patient's cells, they have successfully treated 10,009 people in clinical trials, all of whom are now cancer-free. This method shows promise in curing cancer. Translation: A breakthrough in cancer treatment has been found using mRNA technology. By using a patient's cancer protein, they have treated 10,009 people who are now cancer-free, showing potential in curing cancer.

The speaker developed a protocol, BioStrike, and believes it extended Harry Reid's life. In 2015, the speaker petitioned the FDA to use the treatment at diagnosis, hypothesizing that chemotherapy and radiation wipe out natural killer and T cells. The FDA required testing on end-stage patients who had failed standard care. Despite patients' collapsed immune systems, the speaker reports complete remissions in Merkel cell carcinoma (patient lived six years), bladder cancer (patients alive 10-11 years), triple negative breast cancer, and metastatic pancreatic cancer (patient disease-free after five years, still alive at six). After 700,000 pages of response, the treatment was approved in late 2024. The speaker believes they are on the verge of treating sepsis and cites a recent case of clearing a month-long inflamed lung due to valley fever. The speaker is treating patients with bladder, pancreatic, and lung cancer. The speaker wants to disseminate this information to the scientific, medical, and regulatory communities.

Researchers found a new treatment that removed rectal cancer in all patients in a trial, leading to remission without chemo, radiation, or surgery. The therapy, monoclonal antibodies, showed no toxic side effects and opened up possibilities for fighting other cancers. The study, published in the New England Journal of Medicine, involved 12 patients with advanced rectal cancer who all responded positively to the treatment. Doctor Andrea Cercek described the results as incredible, with patients experiencing normal body functions and no toxicity. Monoclonal antibodies were credited with unlocking the body's healing abilities.

I used my background in physics and optics to find a better way to treat cancer without causing side effects like hair loss. I developed a harmless nanoparticle that heats up when exposed to laser light, killing the tumor cells it touches. By targeting the laser at the tumor site, we were able to completely eliminate tumors in lab mice with just one treatment over 15 days, without any side effects, chemotherapy, surgery, or radiation. This technology has the potential to revolutionize cancer treatment.

Histotripsy is a cancer treatment that uses targeted ultrasound waves to destroy tumors in a non-invasive way. The Edison system, made by Histosonics, is currently the only commercially available histotripsy machine for humans on the market. During treatment, the patient lies on a table and a device called the water bath sits on top of the patient, positioned over the tumor to prepare for therapy. The water bath serves the same purpose as gel in ultrasound imaging, preventing air pockets that would diffuse the ultrasound waves; the water is regular tap water run through a special filter to remove air bubbles. The procedure is performed in an operating room but is not sterile; no incisions are made. The most invasive part is obtaining IV access for sedation and typically anesthesia so the patient remains completely asleep and motionless during therapy. Histotripsy destroys tumor cells by rapidly expanding and contracting the gases inside them, producing a mechanical destruction of tissue rather than a thermal or radiation-based effect. The tissue is liquefied immediately as histotripsy is delivered; there is no waiting period. Dr. Burns showed before-and-after images indicating how the liver tissue healed after histotripsy. Currently, histotripsy is primarily used to destroy liver tumors, but there is potential for application to other body areas. An example patient received histotripsy to a single liver tumor; four months later MRI showed the entire lesion essentially resolved, with only a very small defect remaining and the liver having repaired and reabsorbed the area. Trials mentioned include a primary kidney tumor trial that has just closed, with results awaited, and a pancreatic trial underway in Barcelona, Spain, expected to be available in the US in 2026. Histotripsy is described as a technology platform with potential to expand to every organ, including possible future applications such as prostate (BPH or cancer), uterine fibroids, breast tumors, thyroid nodules, and brain tumors. Air-filled organs pose a challenge because ultrasound waves dissipate in air (lungs, stomach, and intestines). A histotripsy session can take about one to three hours, depending on how many tumors are targeted. Most patients go home a few hours after the procedure; some experience pain or discomfort at the treatment site, and some have no symptoms. Afterward, patients may have systemic inflammatory symptoms (fever, flu-like malaise) starting the day after — considered normal as the body reacts. Histotripsy does not replace all surgeries but may benefit patients who might otherwise require surgery, and the procedure can be repeated multiple times as long as liver function is normal. Histotripsy received FDA approval in October 2023 and is expanding availability as more machines are produced. There are centers near many patients, with expansion planned to the UK and other parts of Asia, as the technology becomes more globally available.

Histosonics' histoTripty, a noninvasive ultrasound technology, has been cleared by the FDA for use in hospitals worldwide. This treatment, known as histotripsy, uses ultrasonic pulses to disrupt tumor cells with minimal recovery time for patients. Liver cancer patients, who often have limited treatment options, could benefit from this precise and effective therapy. The Edison Platform, a robotic arm developed by Histosonics, enables clinicians to target tumors and monitor the treatment in real time. The success of human trials and FDA approval paves the way for histotripsy to be used in a wider patient population, potentially extending its applications to other types of tumors and even non-cancer conditions. This technology has the potential to revolutionize healthcare.

A multiple wave oscillator was used to cure the speaker's father of quadriplegia. After treating him for 4 weeks, 6 weeks later, his father walked out of the hospital on crutches. The speaker also mentions a TED Talk by Anthony Holland, where he explains that frequencies between 100,000 hertz and 300,000 hertz can kill cancer cells. This information challenges the conventional understanding of cancer treatment.

Hystotripsy, a new therapy approved by the FDA, uses ultrasound technology to treat liver cancer. High energy sound waves create micro bubbles in the tumor, causing the cells to break down and kill the tumor. Dr. Chen Chi, a professor at the University of Michigan, compares the procedure to a nanobomb. Initially, many in the scientific community believed ultrasound technology as a treatment would be impossible. However, Hystotripsy shows promise for treating other cancers, cardiovascular and brain diseases, and stimulating the immune system. The treatment is noninvasive, with short recovery time and minimal side effects compared to chemo or radiation. This sound-based therapy offers potential for curing cancer and other diseases without severe side effects.

The speaker discusses promising results for high dose vitamin C in cancer treatment. A recent study on high dose vitamin C shows so much promise, and there have already been human trials underway in which patients who received high dose vitamin C did have drastically improved outcomes: they lived longer and they had less symptoms from the chemo. Mechanistically, the vitamin C literally wipes out the cancer cells via, like, four distinct very strong mechanisms. The speaker also notes that it is very safe as well. In addition, the speaker mentions other natural cancer therapies: ivermectin, fenbendazole, and now dandelion root extract, stating that all of these show extreme promise for natural cancer treatments.

A new cancer treatment called histotripsy, approved by the FDA, uses sound waves to dissolve liver tumors with minimal side effects. This method breaks tumors apart using ultrasound waves, allowing the body's immune system to remove them. Histotripsy is precise, targeting only the tumor, and offers real-time imaging for monitoring. Studies show it may boost the immune system's ability to fight cancer. Patients experience quicker recovery and less discomfort compared to traditional treatments. Histotripsy could become a universal cancer treatment and potentially a cure in the future.

A music professor discusses his moonlight activities in science and the breakthrough he made in cancer research. He explains how he used a resonant frequency therapy device to induce a resonant vibration in living organisms and cells, ultimately shattering them. By finding the magic combination of two input frequencies, he was able to target specific microorganisms. He then conducted experiments on cancer cells, including pancreatic cancer, leukemia, ovarian cancer, and MRSA. The results showed significant destruction of cancer cells and slowed growth rates. He envisions a future where cancer treatment for children is painless and non-toxic, with healing plasma lights above them.

Humans possess natural killer cells, present for 460 million years, that protect against infection, cancer, and trauma. Current cancer treatments like chemotherapy, radiation, and steroid therapy destroy these cells. A new therapy, approved in 2024, aims to activate these natural killer cells, enabling the body to fight cancer. One injection can unlock these cells so they proliferate and protect you from cancer. Bladder cancer patients have remained disease-free for ten years using this therapy. According to the speaker, the prior presidential administration blocked this therapy along with a COVID treatment and vaccine. This therapy may also treat long COVID, HIV, and sepsis. The speaker plans to discuss this further in a series called "Cancer Decoded."

A berry from Australia's blushwood tree, EBC 46, is showing promise in curing various cancers. Animal trials have shown tumors disappearing within 48 hours, leading to human trials with positive results. The injection triggers an immune response, shrinking solid tumors like melanomas and head, neck, and breast cancers. If proven safe and effective, this treatment could be a new option for cancer patients, especially the elderly. The second phase of the trial begins next year.

Welcome to another week of media blackout. Today, we explore the potential of fenbendazole, a low-cost pet medication, as a cancer treatment. Recent case studies show three patients achieving complete remission after using fenbendazole, which works by disrupting cancer cell division. One patient, a 63-year-old man with advanced kidney cancer, saw significant tumor reduction after taking fenbendazole for ten months without side effects. Another patient, a 72-year-old man with metastatic urethral cancer, experienced dramatic lymph node shrinkage after using fenbendazole alongside other supplements. A 63-year-old woman with bladder cancer also reported complete tumor resolution after treatment. These cases suggest fenbendazole could be a safe and effective option for cancer treatment, prompting calls for further research and consideration by drug regulators. As more people share their success stories, the conversation around alternative treatments continues to grow.

A new FDA-approved therapy called AMTOGV is now available at the University of Chicago Medicine to treat melanoma. This treatment, known as tumor infiltrating lymphocyte therapy, involves removing T cells from a tumor, multiplying them in a lab, and infusing them back into the patient. This innovative therapy offers long-term control and potential cure for advanced melanoma patients. Additionally, this treatment may be applicable to other cancers where the immune system can recognize the tumors, such as lung and cervical cancer. Exciting advancements in cancer treatment are on the horizon.

Cancer can be targeted and destroyed using specific frequencies between 100,000 and 300,000 hertz. By adding the 11th harmonic, microorganisms are shattered within about 3 minutes. This process has been observed in various experiments, including attacks on pancreatic cancer and leukemia cells. The destruction of cancer cells leads to changes in shape and size, and the tumor shrinks. Laboratory experiments have shown a 25% to 42% average kill rate for leukemia cells, with some cases reaching 60%. Additionally, the growth rate of cancer can be slowed by up to 65%. This non-toxic and painless treatment can potentially transform cancer treatment rooms for children.

Cancer can be cured using frequencies and resonance therapy, as discovered by Dr. Royal Rife in 1938. He found that by beaming plasma rays of the same frequencies at cancer cells, their vibrations could be amplified and destroyed through resonance. Dr. Rife's machine destroyed 60% of cancer cells in patients. However, his career was destroyed by those who wanted to profit from cancer patients. Despite this, there are still practitioners who continue Dr. Rife's work, such as the engineers at Spooky2. They offer effective and affordable RIFE systems, including the Spooky2 Portable Starter Kit and the Generator X Pro Essential Kit. These kits help with detoxification, boosting energy, and killing harmful microorganisms. Dr. Rife's achievements were documented in various newspapers and he may be recognized as a giant in medical science in the future.

- "Hey. Did you know your liver is basically your body's engine room? It powers your energy, keeps your blood clean, and controls your metabolism." - "Low intensity ultrasound can calm down inflammation, reduce early signs of scarring, boost how your body handles sugar, and help balance your cholesterol and liver enzymes." - "People in early studies saw better energy, clearer thinking, less bloating, and healthier blood markers after consistent use." - "You've got two main targets." - "First is the porta hepatis." - "That's the gateway to your liver." - "It's about two to four centimeters below your right rib cage near the middle." - "The second is directly over the liver tissue." - "For direct liver work, use a low pulsed setting, around 0.08 to 1.5 watts, three to five times a week."

Researchers discovered a groundbreaking treatment for rectal cancer, achieving complete remission in all study participants without chemo, radiation, or surgery. The therapy, using monoclonal antibodies, showed no toxic side effects and opens new possibilities for fighting various cancers. The study, published in the New England Journal of Medicine, involved 12 patients with advanced rectal cancer, all of whom experienced complete clinical responses. Doctors were amazed by the efficacy and lack of toxicity, with patients showing normal body function post-treatment. Monoclonal antibodies were found to unlock the body's healing abilities.

Cancer tumors release fragments into the bloodstream, allowing for early detection through a simple blood test. By utilizing AI, we can identify the most threatening cancers. Additionally, once we sequence the tumor's genes, we can create a personalized mRNA vaccine tailored to the individual. This vaccine can be produced robotically using AI in about 48 hours. This approach promises not only early cancer detection but also the rapid development of customized cancer vaccines, showcasing the potential of AI in transforming cancer treatment.

Using mRNA technology similar to that used for COVID, researchers are taking biopsies of a patient's cancer, extracting protein, and reintroducing it into the patient's cells. In clinical trials, 10,009 humans have been treated. All 10,009 are now cancer free. The researchers claim to have cured cancer.

The FDA has approved a groundbreaking gene editing treatment for sickle cell disease, offering hope to those affected by the debilitating blood disorder. The treatment, called KASGevi, uses CRISPR technology to modify a patient's own stem cells, stopping the production of sickle cells. This breakthrough is seen as transformative for the nearly 100,000 people affected by sickle cell disease. One patient, LaRae, who participated in the clinical trial, has experienced life-changing results. Previously plagued by severe pain, she can now run and work out, something she could never do before. While the treatment comes with a hefty price tag of $2.2 million, insurance is expected to cover some of the cost. The procedure is a one-time treatment, but it is a lengthy and painful process. Despite this, LaRae highly recommends it to others suffering from sickle cell disease.

A single injection of a berry found in Australia's far north is believed to cure many types of cancer. The molecule, EBC 46, derived from the blushwood tree, has shown promising results in shrinking solid tumors in animals and humans. In human trials, tumors disappeared within 48 hours of injection. The treatment triggers an immune response, activating white blood cells to attack the tumor and shrink it. The rainforest remedy could provide a new treatment option for cancer patients, particularly the elderly who may not be able to undergo surgery or chemotherapy. The next phase of the trial will begin next year.

Cancer cells are vulnerable to frequencies between 100000 Hertz and 300000 Hertz, with the higher frequency being 11 times the lower. By adding the 11th harmonic, microorganisms are shattered within 3 minutes. The video shows the destruction of various cancer cells, including pancreatic cancer and leukemia cells. The tumors shrink and break up in controlled experiments. The treatment rooms for children will have healing plasma lights above, shattering cancer cells painlessly.